Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001

被引:16
作者
Detcheva, A
Facklam, RR
Beall, B
机构
[1] Natl Ctr Infect & Parasit Dis, Sofia 1504, Bulgaria
[2] Ctr Dis Control & Prevent, World Hlth Org Collaborating Ctr Streptococci, Atlanta, GA 30333 USA
关键词
D O I
10.1128/JCM.40.10.3831-3834.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The frequency of erythromycin resistance within group A streptococci in Sofia, Bulgaria, from 1995 to 2001 was 2.1% (26 isolates). Of this, 57.7% was macrolide-lincosamide-streptogramin (MLS) inducible, 7.7% was MLS constitutive, and 34.6% had the M phenotype. Eleven different emm sequence types were found among 25 erythromycin-resistant isolates tested. Nineteen of 26 erythromycin-resistant isolates were additionally resistant to tetracycline and/or chloramphenicol.
引用
收藏
页码:3831 / 3834
页数:4
相关论文
共 17 条
[1]   emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci [J].
Beall, B ;
Gherardi, G ;
Lovgren, M ;
Facklam, RR ;
Forwick, BA ;
Tyrrell, GJ .
MICROBIOLOGY-SGM, 2000, 146 :1195-1209
[2]   Macrolide resistance in Streptococcus pyogenes isolates from throat infections in the region of Aachen, Germany [J].
Brandt, CM ;
Honscha, M ;
Truong, ND ;
Holland, R ;
Hövener, B ;
Bryskier, A ;
Lütticken, R ;
Reinert, RR .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 2001, 7 (02) :165-170
[3]   Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes [J].
Clancy, J ;
Petitpas, J ;
DibHajj, F ;
Yuan, W ;
Cronan, M ;
Kamath, AV ;
Bergeron, J ;
Retsema, JA .
MOLECULAR MICROBIOLOGY, 1996, 22 (05) :867-879
[4]  
Comite de l'Antibiogramme de la Societe Francaise de Microbiologie, 1996, CLIN MICROBIOL INFEC, V2, P46
[5]  
DETCHEVA A, 2000, STREPTOCOCCI STREPTO, P289
[6]   Clonal spread of group A Streptococcus with the new type of erythromycin resistance [J].
Kataja, J ;
Huovinen, P ;
Muotiala, A ;
Vuopio-Varkila, J ;
Efstratiou, A ;
Hallas, G ;
Seppälä, H .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :786-789
[7]  
*NAT COMM CLIN LAB, 2000, M7A5 NT COMM CLIN LA
[8]  
National Committee on Clinical Laboratory Standards, 2000, M2A7 NAT COMM CLIN L, V7
[9]   Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain [J].
Perez-Trallero, E ;
Marimón, JM ;
Montes, M ;
Orden, B ;
de Pablos, M .
EMERGING INFECTIOUS DISEASES, 1999, 5 (02) :235-240
[10]   Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants [J].
Roberts, MC ;
Sutcliffe, J ;
Courvalin, P ;
Jensen, LB ;
Rood, J ;
Seppala, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :2823-2830